Global DNA demethylation is a hallmark of embryonic epigenetic reprogramming. Yet, mammalian embryos engage non-canonical DNA methylation-maintenance mechanisms to ensure inheritance of exceptional epigenetic germline features to the soma. Besides the paradigmatic genomic imprints these exceptions remain ill-defined and the mechanisms ensuring demethylation resistance in the light of global reprogramming remain poorly understood. Here we will report how the TRIM28 complex protects genomic imprints from aberrant demethylation during early epigenetic reprogramming. We will further describe how other, non-imprinted genes use this machinery to resist DNA demethylation. In particular, we show that the Y-linked gene Rbmy1a1 is highly methylated in mature sperm and resists DNA demethylation post-fertilization. Aberrant hypomethylation of the Rbmy1a1 promoter results in its ectopic activation causing male-specific periimplantation lethality. Rbmy1a1 is thus a novel target of the TRIM28 complex, which is required to protect its repressive epigenetic state during embryonic epigenetic reprogramming. Insights into the regulation of cell fate decisions in developing embryos may lead to improved methods to derive specific cell types for therapeutic purposes, including skeletal muscle cells. The musclespecific microRNA (myomiR), miR-133, is pivotal for specification of the myogenic lineage; however, the detailed mechanisms by which it exerts its effects remain to be elucidated. We determined the genome-wide effects of miR-133 knockdown (KD) in developing somites, the embryonic source of skeletal muscle, using differential transcriptomics. In addition to negative effects on the key myogenic regulatory factors (MRFs), Myf5 and MyoD, this revealed extensive down-regulation of Sonic hedgehog (Shh) pathway components, including patched receptors (Ptch1 and Ptch2), Hedgehog interacting protein (HHIP) and the transcriptional activator, Gli1. Amongst the de-repressed genes following KD of miR-133 was Gli3, which acts predominantly as a transcriptional repressor and is normally excluded from the myotome, which develops into skeletal muscle. A site in the Gli3-3'UTR was confirmed as a direct target for miR-133 by luciferase reporter assays. A detailed phenotypic analysis of miR-133 KD somites revealed that miR-133 is necessary for cell proliferation and extracellular matrix (ECM) deposition. Loss of miR-133 function led to impaired somite growth and the failure to form and maintain the myotome. It also affected the differentiation of the sclerotome. Together, our data suggests that negative regulation of Gli3R expression by miR-133 enables continued Shh pathway activity, which is critical for somite differentiation and, in particular, myogenesis. Consistent with this, injection of purmorphamine, an activator of the Shh pathway, partially rescued the miR-133 KD phenotype and restored myogenesis. We therefore propose a novel Shh-MRF-miR-133 regulatory network that intimately connects the morphogenesis of the myotome with the activation of the myogenic programme. Inversion and chromosomal translocation potentially create a new configuration of cis-regulatory elements (CREs) and its targeting coding sequences, and thereby evoke novel gene regulation. A mouse old mutation named "Hammer toe (Hm)", which exhibits syndactyly, serves as a good example of acquisition of a new gene expression by genome rearrangement. A map-base cloning of the causative genomic region revealed that there is chromosomal translocation of a 150kb DNA fragment in Chr14 to upstream of Sonic hedgehog (Shh) locus in Chr5. We found that this translocated fragment contains no coding sequence, and Shh is ectopically expressed at interdigital region in the Hm mutant. The syndactyly could be caused by the ectopic Shh expression, which is likely elicited by a new CRE in the translocated fragment. This was confirmed by the fact that the syndactyly phenotype was not observed when the translocation was placed at a cis-position relative to a Shh knockout allele, and that the syndactyly was completely abrogated by removal of the translocated fragment by CRISPR/Cas9-mediated genome edition.
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Orientation-dependent enhancer evoked by chromosomal translocation in mouse Hm mutation Kousuke Mouri, Tomoko Sagai, Takanori Amano, Toshihiko Shiroishi National Institute of Genetics, Mishima, Japan Inversion and chromosomal translocation potentially create a new configuration of cis-regulatory elements (CREs) and its targeting coding sequences, and thereby evoke novel gene regulation. A mouse old mutation named "Hammer toe (Hm)", which exhibits syndactyly, serves as a good example of acquisition of a new gene expression by genome rearrangement. A map-base cloning of the causative genomic region revealed that there is chromosomal translocation of a 150kb DNA fragment in Chr14 to upstream of Sonic hedgehog (Shh) locus in Chr5. We found that this translocated fragment contains no coding sequence, and Shh is ectopically expressed at interdigital region in the Hm mutant. The syndactyly could be caused by the ectopic Shh expression, which is likely elicited by a new CRE in the translocated fragment. This was confirmed by the fact that the syndactyly phenotype was not observed when the translocation was placed at a cis-position relative to a Shh knockout allele, and that the syndactyly was completely abrogated by removal of the translocated fragment by CRISPR/Cas9-mediated genome edition.
Notably, the genome edition unexpectedly induced an inversion of the translocated fragment. It elevated level of the ectopic Shh expression, and as a consequence enhanced the syndactyly phenotype. Moreover, the inversion increased muscle volume in the autopod, caused cleft palate and led to neonatal lethality. These severe phenotypes were never seen in the original Hm mutant. Thus, the CRE in the translocated fragment changed its gene regulatory activity in an orientation-dependent manner.
In conclusion, the Hm mutation provides a useful model system to study how organisms create a novel gene regulation by acquisition of new CREs via genome rearrangements, and generate a morphological novelty.
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Establishment of the three-dimensional genome structure in vertebrate early embryos Ryohei Nakamura, Yuichi Motai, Masahiko Kumagai, Shinichi Morishita, Hiroyuki Takeda
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The three-dimensional organization of a genome plays a key role in gene regulation. Recent studies have revealed that chromatin is folded in a hierarchical manner, and that chromosomes are spatially partitioned into megabase-scale and sub-megabase scale domains, compartments and topologically associating domains (TADs), respectively. However, during animal development, when and how this chromatin organization is established is largely unknown.
Initially in early metazoan development, the zygotic genome is transcriptionally silent, and rapid cell cycles proceed by the control of maternally provided factors. During this process, epigenetic modifications and chromatin accessibilities are globally reprogrammed from the germ-cell (sperm and oocyte)-type to the pluripotent state. After this chromatin reorganization, zygotic genome activation occurs and development starts under the control of zygotic gene products. This developmental event is called midblastula transition (MBT).
In this study, we investigated the dynamics of three-dimensional genome organization during MBT in medaka embryos using Hi-C. We found that the domain structure of the medaka genome is established during this period. Importantly, the pattern of accessible and closed chromatin appeared first, followed by three-dimensional compartmentalization of the genome. We also found that some of the TAD boundaries are correlated with gene transcription. Furthermore, inhibition of zygotic gensome activation by RNA polymerase II inhibitor did not affect the majority of the domain structures, but disrupted some of the TAD boundaries, suggesting that domain formation is mediated by various factors. The development of vertebrate heart is a complex process which involves interaction between multiple signaling pathways at the molecular level, as well as interactions at the cell and tissue level. Disruption of this sophisticated network of interactions results in congenital heart defect (CHD), one of the most common birth defects and is a major cause of heart diseases.
Taking advantage of Danio rerio as the model organism, many molecular pathways have been identified as key regulators of proper heart development. However, despite these advances, there is still a lack of information on their downstream regulatory networks and how they interact.
In our study, we focus on the regulation of heart development by four transcription factors: Hand2, Gata5, Nkx2.5 and Tbx5, shown as the fundamental players of cardiogenesis. We use chromatin immunoprecipitation followed by the next generation sequencing (ChIP-seq) to identify genome-wide binding sites of key cardiac TFs. We investigated the action of these TFs at several stages of heart development: specification of progenitors (15 -16 hours postfertilization, hpf), migration (18 -22 hpf), cells differentiation and heart formation (24 hpf and 48 hpf). In each of these phases TFs play a crucial role in initiating transcription of cardiac genes, leading to the cascade of genetic regulation. Intersection of analysed genomewide binding profiles of these TFs yielded a comprehensive and unbiased map of genome-wide transcriptional targets of key cardiac TFs during cardiogenesis. Moreover, analysis of the genome-wide binding profiles of these TFs allowed the identification of cardiac regulatory elements (enhancers). Here we will present results obtained for two analysed TFs: Gata5 Cranial placodes give rise to many sensory organs and ganglia of the vertebrate head. All placodes arise from a common preplacodal ectodermal domain located around the anterior neural plate and defined by the expression of the transcription factors Six1 and its coactivator Eya1. Six1 and Eya1 continue to be expressed in most placodes and play essential roles for multiple aspects of placode development, including the development of neurons and sensory cells.
To get insights into the gene regulatory network (GRN) upstream of Six1 and Eya1, we used gain and loss of function studies of ectodermal transcription factors in Xenopus laevis. The expression of most ectodermal transcription factors becomes restricted to either ventral (non-neural) or dorsal (neural) parts during gastrulation. Our studies show that genes encoding both ventrally restricted (AP2, Msx1, FoxI1, Vent2, Dlx3, GATA2) and dorsally restricted (Pax3, Hairy2b, Zic1) transcription factors are required for Eya1 and Six1 expression in the preplacodal ectoderm, while conversely Eya1 and Six1 crossregulate these upstream genes.
To analyze the GRN downstream of Six1 and Eya1 we used RNASeq to screen for direct placodal target genes of Six1 and Eya1 by overexpressing hormone-inducible constructs of Six1 and Eya1 in pre-placodal explants, and blocking protein synthesis before hormone-inducing nuclear translocation of Six1 or Eya1. This allowed us to identify hundreds of novel Eya1/Six1 target genes including transcriptional regulators of progenitor fates (e.g. Sox2, Hes5/8) and neuronal/sensory differentiation (e.g. Ngn1, Atoh1, Pou4f1, Gfi1). Gain and loss of function studies showed that Eya1/Six1 (1) are required for placodal expression of these genes and (2) repress/delay neuronal differentiation by directly activating Hes5/8 independent of Notch signaling. The enzyme, protein kinase C (PKC) phosphorylates serine/ threonine residues and plays an important role in post translational modification. PKC isoforms are implicated in fertilization, embryogenesis and differentiation in many organisms including mammals. Although the spatio-temporal expression of PKCs is reported to be tightly controlled, little is known on the molecular mechanism controlling its expression during development. Previous studies in the model organism Dictyostelium discoideum demonstrated that a PKC ortholog (pkcA) is developmentally regulated and plays a critical role in development.
To characterize the mechanism that controls pkcA expression, we cloned an~1.8 kbp promoter segment of pkcA. Deletion analysis indicated a weak repressor and a strong mound-specific prestalk repressor between -1735 to -1525 and -565 to + 1 respectively. In addition, a 962bp 5'-upstream regulatory region was identified whose
